Findings

What do systematic reviews say?

9 questions · 9 findings · 2 reviews

No studies found 7 · 77.8%GRADE not reported 0 · 0%Very low 1 · 11.1%Low 1 · 11.1%Moderate 0 · 0%High 0 · 0%

Acceptability ‐ dropouts due to adverse effects · adults (aged 18 years+) with depression in bipolar disorder

Memantine showed no clear difference in acceptability: dropouts due to adverse effects compared with placebo (low certainty).

1 finding from 1 review

Acceptability ‐ dropouts due to adverse effects · adults (aged 18 years+) with depression in bipolar disorder

The review found no eligible studies for this question.

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acceptability ‐ dropouts due to adverse effects · adults (aged 18 years+) with depression in bipolar disorder

The review found no eligible studies for this question.

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · adults (aged 18 years+) with depression in bipolar disorder

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 16 participants
Very low

Withdrawals due to adverse events · adults (aged 18 years+) with depression in bipolar disorder

The review found no eligible studies for this question.

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · adults (aged 18 years+) with depression in bipolar disorder

The review found no eligible studies for this question.

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · adults with Major Depressive Disorder

The review found no eligible studies for this question.

1 finding from 1 review

Withdrawals due to adverse events · adults with Major Depressive Disorder

The review found no eligible studies for this question.

1 finding from 1 review

Withdrawals due to adverse events · adults with Major Depressive Disorder

The review found no eligible studies for this question.

1 finding from 1 review